- Clinical Trials
- October 2024
- 294 Pages
Global
From €3090EUR$3,450USD£2,634GBP
- Report
- January 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 74 Pages
Global
From €8952EUR$9,995USD£7,631GBP
- Report
- August 2024
- 322 Pages
Global
From €2194EUR$2,450USD£1,871GBP
- Report
- August 2024
- 120 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- May 2025
- 188 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 199 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- August 2024
- 120 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- March 2025
- 200 Pages
Global
From €2230EUR$2,490USD£1,901GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- January 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- January 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- January 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 383 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 194 Pages
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- June 2025
- 182 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 282 Pages
Global
From €5240EUR$5,850USD£4,467GBP

Uveitis is a medical condition that affects the uvea, the middle layer of the eye. It is characterized by inflammation of the uvea, which can lead to vision loss and other complications. In the context of optical, uveitis is a major cause of vision loss and can be treated with a variety of treatments, including topical and systemic medications, laser treatments, and surgery.
Uveitis is a growing market in the optical industry, as it is a common cause of vision loss and can be treated with a variety of treatments. Companies in the uveitis market include Bausch + Lomb, Novartis, Allergan, and Santen Pharmaceuticals. These companies offer a range of treatments for uveitis, including topical and systemic medications, laser treatments, and surgery. Show Less Read more